Intercept Pharmaceuticals Inc ICPT

NAS: ICPT | ISIN: US45845P1084 26/05/2023

10,26 USD (+5,23%)

(+5,23%) 26/05/2023

Toon enkel gratis nieuws

7 januari 2022 · Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers - ICPT · Persbericht

10 maart 2021 · Intercept Announces Departure of Chief Financial Officer · Persbericht

19 februari 2021 · Intercept to Present at Upcoming Investor Conferences · Persbericht

27 januari 2021 · Intercept Company Statement on Analyst Note · Persbericht

4 januari 2021 · ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc. · Persbericht

4 januari 2021 · DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

3 januari 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe